Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

(2021) Merryn Voysey et al.   LANCET

Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19

(2021) Houssein H Ayoub et al.   Journal of Global Health

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

(2021) Laith J. Abu-Raddad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose

(2021) Catherine J. Reynolds et al.   SCIENCE

Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic

(2021) Laith J. Abu-Raddad et al.   Scientific Reports

SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study

(2021) Andrew G Letizia et al.   Lancet Respiratory Medicine

SARS-CoV-2 infection is at herd immunity in the majority segment of the population of Qatar

(2021) Mohamed H Al-Thani et al.   Open Forum Infectious Diseases

Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar

(2021) Mohammad R. Hasan et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar

(2021) Roberto Bertollini et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses

(2021) Laith J Abu-Raddad et al.   JOURNAL OF TRAVEL MEDICINE

mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar

(2021) Hiam Chemaitelly et al.   NATURE MEDICINE

SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar

(2021) Shaheen Seedat et al.   Scientific Reports

SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals

(2021) Peter V. Coyle et al.   iScience

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research

(2009) Peter C. Austin   COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION